amiodarone has been researched along with Multiple Primary Neoplasms in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schlesinger-Irsch, UR | 1 |
| Perlewitz, O | 1 |
| Nelles, M | 1 |
| Maoz, KB | 1 |
| Dvash, S | 1 |
| Brenner, S | 2 |
2 other studies available for amiodarone and Multiple Primary Neoplasms
| Article | Year |
|---|---|
Topics: Amiodarone; Brain Neoplasms; Defibrillators, Implantable; Diagnosis, Differential; Glioblastoma; Hum | 2019 |
Amiodarone-induced skin pigmentation and multiple basal-cell carcinomas.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Carcinoma, Basal Cell; Color; Dermis; Humans; Male; Micros | 2009 |